522 related articles for article (PubMed ID: 34743358)
1. Serum iron indices in COVID-19-associated mucormycosis: A case-control study.
Kumar H M; Sharma P; Rudramurthy SM; Sehgal IS; Prasad KT; Pannu AK; Das R; Panda NK; Sharma N; Chakrabarti A; Agarwal R; Muthu V
Mycoses; 2022 Jan; 65(1):120-127. PubMed ID: 34743358
[TBL] [Abstract][Full Text] [Related]
2. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
Rao C; R M
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
[TBL] [Abstract][Full Text] [Related]
3. Coronavirus disease-associated mucormycosis (CAM): A case control study during the outbreak in India.
Wasiq M; K R; Gn A
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443518
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for COVID-19 associated mucormycosis in India: A case control study.
Patel AK; Bakshi H; Shah K; Patel S; Patel T; Patel K; Patel KK
Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35709394
[TBL] [Abstract][Full Text] [Related]
5. Serum glucose-regulated protein 78 (GRP78) levels in COVID-19-associated mucormycosis: results of a case-control study.
Muthu V; Dhaliwal M; Sharma A; Nair D; Kumar HM; Rudramurthy SM; Sehgal IS; Choudhary H; Panda N; Chakrabarti A; Agarwal R
Mycopathologia; 2022 Aug; 187(4):355-362. PubMed ID: 35727491
[TBL] [Abstract][Full Text] [Related]
6. Association of iron-related biomarkers with severity and mortality in COVID-19 patients.
Yadav D; Pvsn KK; Tomo S; Sankanagoudar S; Charan J; Purohit A; Nag V; Bhatia P; Singh K; Dutt N; Garg MK; Sharma P; Misra S; Purohit P
J Trace Elem Med Biol; 2022 Dec; 74():127075. PubMed ID: 36174458
[TBL] [Abstract][Full Text] [Related]
7. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for Coronavirus disease-associated mucormycosis.
Arora U; Priyadarshi M; Katiyar V; Soneja M; Garg P; Gupta I; Bharadiya V; Berry P; Ghosh T; Patel L; Sarda R; Garg S; Agarwal S; Arora V; Ramprasad A; Kumar A; Garg RK; Kodan P; Nischal N; Singh G; Jorwal P; Kumar A; Baitha U; Meena VP; Ray A; Sethi P; Xess I; Vikram N; Sinha S; Biswas A; Thakar A; Bhatnagar S; Trikha A; Wig N
J Infect; 2022 Mar; 84(3):383-390. PubMed ID: 34974056
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors of COVID-19 Associated Mucormycosis (CAM) in Iranian Patients: A Single-Center Retrospective Study.
Tavakolpour S; Irani S; Yekaninejad MS; Alimardi M; Hasibi M; Abdollahi H; Kazemi MA; Lotfi M; Shahbazian H; Nazemian Yazdi NA; Samimiardestani S; Firouzifar M; Farahbakhsh F; Mirzaee Goodarzi M; Feiz F; Salehinia F
Mycopathologia; 2022 Dec; 187(5-6):469-479. PubMed ID: 36202942
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World.
Muthu V; Rudramurthy SM; Chakrabarti A; Agarwal R
Mycopathologia; 2021 Dec; 186(6):739-754. PubMed ID: 34414555
[TBL] [Abstract][Full Text] [Related]
11. Cross-sectional study to describe the severity, bio-chemical associations, and final outcomes of COVID-19-associated rhino-orbital-cerebral mucormycosis in a tertiary hospital of East India.
Kumari A; Ranjan A; Nishant P; Sinha S; Sinha RK
Indian J Ophthalmol; 2023 May; 71(5):2193-2198. PubMed ID: 37202947
[TBL] [Abstract][Full Text] [Related]
12. Aspergillosis and Mucormycosis in COVID-19 Patients: A Systematic Review.
Afzal S; Nasir M
J Coll Physicians Surg Pak; 2022 May; 32(5):639-645. PubMed ID: 35546702
[TBL] [Abstract][Full Text] [Related]
13. Serum iron and total iron-binding capacity compared with serum ferritin in assessment of iron deficiency.
Peter F; Wang S
Clin Chem; 1981 Feb; 27(2):276-9. PubMed ID: 7460279
[TBL] [Abstract][Full Text] [Related]
14. Perturbations of immune landscape in COVID-19 associated mucormycosis.
Desai N; Pradhan V; Chougule D; Tiwari S; Mandke C; Yadav RM; Athvale A; Kawle J; Pai V; Pawaskar S; Kharkar H; Bhosale S; Parab A; Ansari S; Kumar KH; Mhashal S; Redkar N; Madkaikar M
Mycoses; 2023 Mar; 66(3):226-236. PubMed ID: 36380699
[TBL] [Abstract][Full Text] [Related]
15. Clinical Features and Mortality of COVID-19-Associated Mucormycosis: A Systematic Review and Meta-Analysis.
Watanabe A; So M; Mitaka H; Ishisaka Y; Takagi H; Inokuchi R; Iwagami M; Kuno T
Mycopathologia; 2022 Jun; 187(2-3):271-289. PubMed ID: 35312945
[TBL] [Abstract][Full Text] [Related]
16. Diabetes and Covid Associated Mucormucormycosis-A Cross Sectional Study in Kilpauk Medical College.
Pradeepkumar V
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443380
[TBL] [Abstract][Full Text] [Related]
17. Is there an association between zinc and COVID-19-associated mucormycosis? Results of an experimental and clinical study.
Muthu V; Kumar M; Paul RA; Zohmangaihi D; Choudhary H; Rudramurthy SM; Panda NK; Pannu AK; Sharma N; Sharma S; Chakrabarti A; Agarwal R
Mycoses; 2021 Oct; 64(10):1291-1297. PubMed ID: 34420245
[TBL] [Abstract][Full Text] [Related]
18. Multimodal analysis of the COVID-19-associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors.
Chowdhary A; Gupta N; Wurster S; Kumar R; Mohabir JT; Tatavarthy S; Mittal V; Rani P; Barman P; Sachdeva N; Singh A; Sharma B; Jiang Y; Cuomo CA; Kontoyiannis DP
Mycoses; 2023 Jun; 66(6):515-526. PubMed ID: 36790120
[TBL] [Abstract][Full Text] [Related]
19. Higher ferritin levels, but not serum iron or transferrin saturation, are associated with Type 2 diabetes mellitus in adult men and women free of genetic haemochromatosis.
Yeap BB; Divitini ML; Gunton JE; Olynyk JK; Beilby JP; McQuillan B; Hung J; Knuiman MW
Clin Endocrinol (Oxf); 2015 Apr; 82(4):525-32. PubMed ID: 24953981
[TBL] [Abstract][Full Text] [Related]
20. Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021.
Buil JB; van Zanten ARH; Bentvelsen RG; Rijpstra TA; Goorhuis B; van der Voort S; Wammes LJ; Janson JA; Melchers M; Heusinkveld M; Melchers WJG; Kuijper EJ; Verweij PE
Euro Surveill; 2021 Jun; 26(23):. PubMed ID: 34114540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
